NASDAQ : HKPD
-$0.02 (-6.18%)
NASDAQ
Chenyu Liang
Medical - Pharmaceuticals
Healthcare
HKPD
27
HK
USD
0.44
2.93
2.73
0.06
0.00
$20.31M
0.22
0.71
-7.38
-0.04
-$0.003
-$27056
-4.29%
-4.71%
-13.85%
-7.29%
-4.85
0.04
0.04
2/5
0 Analysts
%
5.02
4/9
$5.81M
$9.42M
$4.43M
$190.25K
$5.96M
0.36
-11.14
2.93
-13.85%
-8.91%
-18.08%
-12.71%
100 days
| Name | Title |
|---|---|
| Chenyu Liang | Chief Executive Officer & Director |
| Zifeng Wang | Chief Strategy Officer |
| Shu Liu | Chief Financial Officer |
No votes yet today — be the first to share your view!
About Cellyan Biotechnology Co., Ltd (NASDAQ:HKPD) Stock
Cellyan Biotechnology Co., Ltd, an investment holding entity, primarily operates within the over-the-counter (OTC) pharmaceutical sector, serving markets across Hong Kong and mainland China. The company's services encompass the international sourcing and distribution of OTC medications, alongside comprehensive e-commerce supply chain management. Furthermore, it provides essential logistical support, including customs clearance, drug registration, and warehousing facilities. Cellyan Biotechnology caters to a diverse clientele, which includes logistics partners for e-commerce platforms, various merchants, and pharmaceutical distributors. Founded in 2023, the company is based in Yau Tong, Hong Kong. It was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and officially a ... dopted the name Cellyan Biotechnology Co., Ltd in December 2025.
Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Additional Compliance Grace Period
2026-07-16 16:30:00
HONG KONG, July 16, 2026 (GLOBE NEWSWIRE) -- Cellyan Biotechnology Co., Ltd (Nasdaq: HKPD) (the "Company"), a leading provider of over the counter (“OTC”) pharmaceutical cross-border e-commerce supply chain services in Hong Kong, today announced that it received a notification letter (the “Notification Letter”) on July 14, 2026 from Nasdaq's Listing Qualifications Department indicating that the Company has been granted an additional 180 calendar day period, or until January 11, 2027, to regain compliance with the Nasdaq's minimum $1.00 closing bid price requirement (“the Minimum Bid Price Requirement”) as set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on Nasdaq. To regain compliance with the Minimum Bid Price Requirement, the Company must maintain a closing bid price of the Company's Class A ordinary shares at least $1.00 per share for a minimum of ten consecutive business days on or prior to the end of the 180-day extension period, or January 11, 2027.
Frequently Asked Questions
What is the current Cellyan Biotechnology Co., Ltd (HKPD) stock price?
Cellyan Biotechnology Co., Ltd(NASDAQ:HKPD) stock price is $0.331 in the last trading session. During the trading session, HKPD stock reached the peak price of $2.58 while $0.31 was the lowest point it dropped to. The percentage change in HKPD stock occurred in the recent session was --6.18% while the dollar amount for the price change in HKPD stock was -$0.02.
HKPD's industry and sector of operation?
The NASDAQ listed HKPD is part of Medical - Pharmaceuticals industry that operates in the broader Healthcare sector.
Who are the executives of HKPD?
Chenyu Liang
| Chief Executive Officer & Director
Zifeng Wang
| Chief Strategy Officer
Shu Liu
| Chief Financial Officer
|
|
How many employees does HKPD have?
Number of HKPD employees currently stands at 27. HKPD operates from Well Town Industrial Building, Yau Tong, None 999077, HK.
Link for HKPD official website?
Official Website of HKPD is: http://www.9zt.hk
How do I contact HKPD?
HKPD could be contacted at phone #852 2618-9289 and can also be accessed through its website. HKPD operates from Well Town Industrial Building, Yau Tong, None 999077, HK.
How many shares of HKPD are traded daily?
The average number of HKPD shares traded daily for last 3 months was 452.76K.
What is the market cap of HKPD currently?
The market value of HKPD currently stands at $3.63M with its latest stock price at $0.331